Elizabeth M. Bradshaw, PhD, is the Adler Assistant Professor of Neurological Sciences in the Department of Neurology and the Taub Institute and Co-Director of the Carol and Gene Ludwig Center for Research on Neurodegeneration at Columbia University Irving Medical Center. Dr. Bradshaw is a translational neuroimmunologist whose research focuses on how immune mechanisms influence neurodegenerative diseases, including Alzheimer’s disease, Parkinson’s disease, and amyotrophic lateral sclerosis. Her laboratory studies microglia, the brain’s resident immune cells, with an emphasis on how genetic and environmental factors reshape immune function in disease. By generating microglia-like cells from human blood, her work integrates human genetics with cellular and molecular immunology to define disease-relevant immune pathways. Dr. Bradshaw’s overarching goal is to translate fundamental discoveries in neuroimmunology into therapeutic strategies that modify disease trajectories.
Associated Grants
-
Investigating the Role of Immune Cell Exhaustion (ICE) and Biological Immune Aging (BIA) in PD Risk and PD Heterogeneity
2026